Amcal

Quick links to important sections

Amcal

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amcal

What is Amcal? Drug Identity and Purpose Overview

Amcal is a prescribed medication featuring Amlodipine as its active ingredient, a compound designed to act on the cardiovascular system. It functions as an Antihypertensive Agent, helping the body regulate blood pressure and vascular flow.

Property Description
Active ingredient Amlodipine (Amlodipine besilate)
Form Oral tablet (Single-ingredient)
Pharmacological class Dihydropyridine Calcium Channel Blocker (CCB)
Common use Management of high blood pressure and angina
Origin Synthetic chemical compound

What Type of Medicine is Amcal (Amlodipine)?

Amcal is pharmacologically categorized as a Calcium Channel Blocker (CCB), specifically falling within the Dihydropyridine subclass. This classification means the substance selectively targets calcium channels found primarily in the walls of the blood vessels. The drug is a synthetic molecule formulated for oral administration as a simple tablet.

The efficacy of Amlodipine in managing sustained high blood pressure is supported by extensive clinical recognition within international treatment guidelines. Its long-acting profile makes it distinctively suitable for maintenance therapy, simplifying the regimen compared to some shorter-acting agents.

Composition and Origin of Amcal

The functional substance in the tablets is Amlodipine, which is chemically synthesized and typically stabilized as the besilate salt to ensure consistency and stability in the final dosage form. As an oral tablet, Amcal is a single-ingredient product composed of the active compound combined with solid oral excipients necessary for manufacturing and consistent delivery.

General Purpose of a Calcium Channel Blocker

The overarching purpose of Amcal is to manage cardiovascular health by directly influencing the muscular tone of the arteries. By achieving this, the medicine helps to lower high blood pressure by reducing the resistance against which the heart pumps blood. For instance, it is typically used in the sustained management of chronic stable angina, demonstrating its therapeutic value in promoting healthier circulatory dynamics.

This action also eases the overall workload on the heart and supports improved blood flow to the heart muscle. Amlodipine is clinically recognized for its favorable tolerability profile compared to some older CCBs, making it a commonly chosen option for long-term therapy.

What side effects are possible with Amcal?

Possible Side Effects and Safety Information

Amcal (Amlodipine) is associated with an official safety profile categorized by the frequency and physiological system affected, as documented by government regulatory agencies. Side effects are classified into frequency bands based on clinical trial data, establishing the potential for their occurrence.


Official Adverse Reaction Frequencies

Classification Examples of Adverse Reactions
Very Common Ankle swelling (Oedema)
Common Headache, Dizziness, Palpitations, Flushing, Nausea, Fatigue

These effects are organized across various System-Organ Classes, with common reactions frequently involving the Nervous system (e.g., headache, somnolence), Vascular system (flushing), and General disorders (fatigue, oedema). Safety documents note that certain reactions, such as headache and oedema, may be observed more frequently at the start of treatment or following a dose increase.


Documented Safety Constraints and Serious Reactions

The regulatory profile includes documentation of serious adverse reactions, which occur infrequently, such as hepatic impairment (jaundice, hepatitis) and severe skin conditions like Stevens-Johnson syndrome. Use is officially restricted, or contraindicated, in specific severe cardiovascular states, including severe hypotension, cardiogenic shock, and significant aortic stenosis.

Population-specific safety considerations state that caution is required for individuals with impaired hepatic function due to reduced clearance of the medicine, which can result in increased systemic exposure. The same factor of reduced clearance is also noted for older adults.

Overdose and Emergency Response

The official regulatory documents define the overdose profile of Amcal (Amlodipine) based on its powerful cardiovascular effects. The core documented manifestation is profound and prolonged hypotension (low blood pressure), which may lead to associated signs such as dizziness, fainting (syncope), rapid heartbeat (tachycardia), or in some cases, slow heartbeat (bradycardia). Severe or life-threatening outcomes officially documented include cardiovascular collapse, seizure, and respiratory difficulty.

In the event of a suspected overdose, immediate medical attention must be sought without delay. Regulators mandate that individuals call emergency services (e.g., 911) immediately if severe signs are present, such as collapse, seizure, or inability to be awakened. Contacting a poison control helpline is also an official procedural step.

Treatment for Amlodipine overdose is defined as symptomatic and supportive, as there is no specific antidote known. Management involves procedures such as gastric emptying or activated charcoal if administered shortly after ingestion. Due to the drug’s long half-life, active cardiac and respiratory monitoring in a hospital setting is required, along with cardiovascular support, including the administration of intravenous fluids and vasopressor agents for persistent, severe low blood pressure.

Therapeutic Uses of Amcal

What Amcal treats: Main Uses and Benefits

Amcal (Amlodipine) is commonly used for managing conditions characterized by periods of heightened symptoms. The medication is relevant across therapeutic domains where additional symptomatic support is needed. It is primarily used to address symptoms associated with conditions marked by increased physiological stress, namely Hypertension and Angina.

Therapeutic Focus and Symptom Relief

Amcal contributes to easing the overall symptom load associated with chronic high blood pressure by helping manage sustained blood pressure elevation. It is also relevant for managing symptoms that become more disruptive during flare-ups, such as recurrent chest pain and pressure linked to Angina.

“The medication supports the patient during episodes of heightened discomfort and assists with maintaining functional stability when symptoms create noticeable physiological strain.”

This contributes to improving day-to-day comfort during symptomatic periods and helps patients cope more steadily with symptom fluctuations.


Quick Fact: Supportive Relief for Systemic Imbalance Amcal is relevant in clinical settings marked by increased discomfort or tension, applied in scenarios where additional management of discomfort is required due to conditions associated with acute or disruptive episodes.


Eligibility and Restrictions for Use

Official Eligibility Profile for Amcal (Amlodipine)

Official regulatory documents define strict criteria for the use of Amcal, establishing both allowed and prohibited populations. The following information reflects mandatory label-based eligibility status.

Eligibility Status Population Group Constraint Basis (Per Label)
Contraindicated Patients with known hypersensitivity to amlodipine or other dihydropyridine derivatives Absolute prohibition due to allergic risk
Contraindicated Patients experiencing severe hypotension, cardiogenic shock, or unstable heart failure after acute myocardial infarction Acute cardiovascular instability
Allowed Adults for both Hypertension and Angina management Established safety and efficacy profile
Restricted Pediatric patients under 6 years old Safety and efficacy not established; insufficient data
Restricted Older adults or patients with hepatic impairment Requires lower initial dose due to decreased drug clearance and greater risk of organ impairment
Not Recommended Pregnant women Safety not established; use only if the potential benefit justifies the risk
Not Recommended Nursing mothers Drug is excreted in human milk; potential effect on infant is unknown

What should I know about interactions with other medicines?

Interactions with other medicines and products

Amcal (Amlodipine) is associated with several officially documented interaction patterns, primarily involving the drug's metabolic pathway and its additive clinical effects.

Pharmacokinetic interactions occur because Amlodipine is metabolized by the CYP3A4 enzyme. Co-administration with strong or moderate CYP3A4 inhibitors (such as clarithromycin or ketoconazole) increases the systemic exposure of Amlodipine, potentially leading to increased blood pressure lowering. Conversely, CYP3A4 inducers (such as rifampicin) may reduce Amlodipine concentrations and efficacy.

Documented Interaction Constraints

Partner Agent Interaction Type Regulatory Restriction/Outcome
Simvastatin Pharmacokinetic Amlodipine increases Simvastatin exposure; Simvastatin dose must be limited to 20 mg daily when co-administered.
Tacrolimus Pharmacokinetic Amlodipine increases Tacrolimus plasma levels, requiring monitoring of Tacrolimus blood concentration.
Other Antihypertensives Pharmacodynamic Additive blood pressure lowering effect; increased risk of hypotension.
Grapefruit/Grapefruit Juice Pharmacokinetic May increase Amlodipine exposure and enhance hypotensive effects.

These interactions are generally managed by careful monitoring and dose management, rather than outright contraindication. The interaction leading to increased exposure with CYP3A4 inhibitors is noted to be more pronounced in patients with severe hepatic impairment, requiring heightened caution in this specific population.

Mechanism of Action

The mechanism of Amcal (Amlodipine) is defined by its selective action on the muscular tone of the arteries, achieved through direct modulation of calcium ion movement.

Calcium Channel Blockade in Vascular Smooth Muscle

The core mechanism involves the selective blockade of L-type Voltage-Dependent Calcium Channels ( L-VDCCs). Amlodipine acts as an antagonist, physically preventing the influx of extracellular calcium ions ( Ca^2+) into the vascular smooth muscle cells. This molecular interference is the initial step that halts the excitation-contraction coupling pathway in the vessel, dictating its muscle tone.

Modulation of Systemic Vascular Resistance

By blocking Ca^2+ influx, the smooth muscle relaxes, causing the arteries and arterioles to widen (vasodilation). This widening produces the systemic physiological consequence of reducing Peripheral Vascular Resistance (PVR), the total resistance the heart must overcome to pump blood. The mechanism is highly vascular selective, resulting in reduced interaction with L-VDCCs in the cardiac conduction tissue and myocardium.

Sustained Action via Slow Kinetics

The duration of Amlodipine's effect is a feature of its mechanism, characterized by a slow rate of dissociation from the L-VDCC binding site. This sustained molecular interaction ensures a continuous level of arterial relaxation. This slow-acting profile results in a gradual systemic effect that attenuates the compensatory baroreceptor reflex that would typically trigger reflex tachycardia following rapid vasodilation.

Dosage and Administration Information

Amcal (Amlodipine) is approved for once-daily oral administration as a component of long-term maintenance therapy. The medicine is designed to be taken consistently at approximately the same time each day to maintain steady blood concentrations throughout a 24-hour period. A key principle of its use is flexibility regarding meals, as Amlodipine can be taken with or without food without affecting its absorption or efficacy.


Standard Dosing Regimens

The usage instructions define specific starting doses. For most adults, the initial recommended dose is 5 mg once daily. Dosage adjustments, if required, must be done gradually, with an interval of 7 to 14 days between changes to properly evaluate the therapeutic response. The standard dose range is 5 mg to 10 mg daily, with a maximum recommended dose of 10 mg once daily.


Specific Population Rules

For certain patient groups, a lower initial dose is required. Due to potentially reduced clearance, older adults (geriatric patients) and those with hepatic impairment (liver function issues) are often started at a lower dose of 2.5 mg once daily. For pediatric patients between 6 and 17 years old, the official dosing range is 2.5 mg to 5 mg once daily, and doses exceeding 5 mg are not studied or recommended for this age group. No initial dose adjustment is necessary for patients with renal impairment.

Recent Clinical Evidence

Amcal: Recent Clinical Evidence

Clinical evidence summaries focus on what research has found regarding Amcal (which may contain ingredients like paracetamol or a paracetamol/codeine combination, depending on the specific product). Research is designed to evaluate how the compound acts, its clinical results, and its safety profile across different populations.


Mechanism and Efficacy Studies

Research evaluated the compound’s action, noting that studies examined a potential effect on neurotransmitter release. Early studies explored the interaction of the compound with specific receptor types, potentially suggesting an action within the central nervous system.

Randomized controlled trials (RCTs) have evaluated whether this compound might be associated with a change in reported pain levels among participants with various conditions, such as chronic back pain. Some studies documented a rapid initial response, but evidence regarding long-term effectiveness remains mixed, suggesting further research is needed to understand potential sustained effects.


Tolerability and Comparative Research

Dosage and Administration: Studies explored the effect of co-administration with food on the compound’s absorption and tolerability. Research indicated that larger doses were associated with a higher incidence of reported adverse events without a clear correlation to improved efficacy.

Safety Profile: The side effect profile was documented in clinical trials, and researchers characterized the risk-benefit profile in studied populations. The most commonly reported events included nausea and headaches. Trial data reported instances of palpitation, and the compound has been studied with caution in populations with pre-existing heart conditions.

Comparative Effectiveness: Meta-analyses examined whether there was an association with outcome when the compound was used alongside treatments like physical therapy. These analyses frequently concluded that larger, independent RCTs would be required to establish any definitive differences in therapeutic results compared to placebo or other common treatments.

Frequently Asked Questions (FAQ)

Common questions about Amcal (FAQ)


Q: How long after starting Amcal do people typically notice an effect?

A: According to official product information, peak blood levels of the medicine are typically reached between 6 and 12 hours after a single oral dose. Clinically significant reductions in blood pressure are observed throughout the 24-hour period with once-daily dosing. The slow absorption profile is associated with a gradual change in systemic effects.


Q: Does Amcal interact with common over-the-counter pain relievers?

A: Regulatory information indicates that the co-administration of Nonsteroidal anti-inflammatory drugs (NSAIDs) with Amcal may be associated with a reduced blood pressure-lowering effect and an increased risk of specific side effects. Acetaminophen is not often noted in the official interaction documents concerning this specific mechanism.


Q: How long does Amcal stay in the body after the last dose?

A: Official pharmacological documents describe Amcal as having a terminal plasma elimination half-life of approximately 35 to 50 hours. This relatively long duration of action is the reason the medication is suitable for a once-daily regimen.


Q: What kind of studies support the use of Amcal?

A: The use of this medicine is supported by clinical trials, including randomized, placebo-controlled trials, which evaluated the drug's effects on the management of high blood pressure and angina in studied populations. Official sources describe the medicine’s efficacy as being supported by extensive clinical recognition.


Q: Can Amcal be taken alongside supplements like Vitamin D or magnesium?

A: Regulatory guidance suggests that individuals should inform their healthcare provider of all products they are taking. This includes prescription and nonprescription medicines, as well as vitamins, nutritional supplements, and any herbal products. A healthcare provider is required to determine the appropriateness of taking supplements alongside this medication.


Q: Does Amcal affect mood or mental clarity?

A: Side effect reports filed with regulatory agencies include some effects on the nervous and psychiatric systems. Common reported effects include somnolence (drowsiness) and dizziness. Uncommon reported psychiatric effects include insomnia, mood changes (such as anxiety), and depression.


Q: How does Amcal compare to other common medications for the same condition?

A: Amcal is officially categorized as a dihydropyridine calcium channel blocker (CCB). This classification means its mechanism of action is distinct from other classes of blood pressure medication, such as beta-blockers or ACE inhibitors, as it works primarily by directly relaxing blood vessels.


Q: Can Amcal be taken by people who have mild kidney issues?

A: Official prescribing information indicates that kidney impairment does not significantly influence how the body processes Amlodipine. Therefore, the official prescribing information indicates that no initial dosage adjustment is necessary for patients with renal impairment.


Q: Do many users experience weight change while taking Amcal?

A: Ankle swelling (oedema) is a Very Common adverse reaction reported in clinical data. Weight change is not listed as a common side effect in the official documents.


Q: What happens if I forget to take a dose of Amcal?

A: Regulatory documents include specific guidelines for managing a missed dose. These instructions clarify when to take the next dose and advise against double dosing, as the medicine is designed for once-daily use.


Q: Is it okay to stop taking Amcal suddenly?

A: Official guidance describes that abruptly stopping the medication may be associated with potential risks, such as increases in blood pressure, and should only be done under the direction of a healthcare professional.


Q: Is Amcal safe for use during pregnancy?

A: Official labeling notes that there are no controlled data available for the use of this medicine in pregnant women. Its use is generally restricted to situations where the potential benefit is judged to outweigh the potential risk to the fetus.


Q: What are the general rules for using Amcal while breastfeeding?

A: The drug is known to be excreted in human milk, and official documents note that the potential effect on the infant is unknown. Therefore, a decision is typically required to discontinue either nursing or the use of the drug.


Q: Is Amcal available as a generic medication?

A: Yes, the active ingredient Amlodipine, which is in Amcal, is widely available as a generic medication.


Q: What happens if Amcal is taken with alcohol?

A: Official warnings note that Amcal and alcohol can have additive effects in lowering blood pressure. This may increase the chances of symptoms like dizziness, lightheadedness, or fainting. The potential for additive effects means that avoiding excessive alcohol consumption is a common caution noted in patient materials.


Q: Is it normal to feel slightly dizzy when first starting Amcal?

A: Dizziness is officially listed as a Common side effect of the medicine. Safety documents report that certain reactions, including dizziness and headache, may be observed more frequently when treatment is first initiated or following a dose increase.


Q: What is the difference between Amcal and a placebo in clinical trials?

A: In clinical trials, a placebo is an inactive substance that does not contain the drug, used to measure effects through comparison. The trials supporting Amcal's effectiveness were placebo-controlled, meaning the drug’s observed effect on blood pressure was measured against the effects noted in patients receiving only the inactive substance.


Q: How often do people need to adjust their Amcal usage?

A: Official guidelines state that any necessary dosage adjustments must be conducted gradually, requiring an interval of 7 to 14 days between changes to properly evaluate the therapeutic response. Once a stable dose is achieved, treatment is typically long-term and stable.


Q: Are there any specific lifestyle changes recommended when starting Amcal?

A: Official information indicates that this medication is typically one part of a comprehensive management strategy, which often includes non-pharmacological measures such as dietary management, weight control, and physical activity.


Q: How does Amcal affect blood pressure?

A: Amcal is a calcium channel blocker designed to dilate, or widen, the peripheral arterioles (small arteries). This action reduces the total resistance the heart must overcome to pump blood throughout the body. This direct relaxant effect on the blood vessel walls leads to a reduction in high blood pressure.


Q: Is it true that Amcal might cause changes in vision?

A: Official adverse reaction reports classify visual disturbance, which can include double vision, as an Uncommon side effect. Rare ocular side effects have also been reported in post-marketing surveillance, as documented in regulatory safety materials.


Q: What should be done if an interaction with another drug is suspected?

A: The regulatory documents state that decisions regarding managing suspected interactions, which may involve adjusting medication doses or increased monitoring, must be made by a healthcare provider or pharmacist.

How should Amcal be stored and disposed of?

How to Store and Dispose of Amcal (Amlodipine)

Amcal tablets must be stored under specific environmental conditions to maintain stability and prevent accidental ingestion, as defined by official regulatory labeling.


Storage Requirements

  • Temperature Control: Store at Controlled Room Temperature (20 C to 25 C), protecting the product from excessive heat.
  • Protection: The medicine must be kept in light-resistant containers and stored in a dry place, shielding it from light and moisture.
  • Child Safety: Amcal must be kept out of sight and reach of children at all times.

Disposal Instructions

Expired or unused tablets should be disposed of in accordance with official protocol. Patients must return unused medicine to a pharmacist for proper disposal through an approved program. The product must not be flushed down the toilet or released into the sanitary sewer system.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amcal found in:

A-Z Index: